ADCOCK INGRAM HOLDINGS LIMITED - Update on the acquisition of certain assets of Cosme Farma Laboratories Limited (India)
AIP 201211010020A
Update on the acquisition of certain assets of Cosme Farma Laboratories Limited (India)
Adcock Ingram Holdings Limited
(Registration number 2007/016236/06)
(Incorporated in the Republic of South Africa)
Share code: AIP
ISIN: ZAE000123436
("Adcock Ingram")
UPDATE ON THE ACQUISITION OF CERTAIN ASSETS OF COSME FARMA LABORATORIES LIMITED (INDIA)
Shareholders are referred to the announcement released by Adcock Ingram on SENS on 10 July 2012, relating
to the acquisition by Adcock Ingram through its wholly owned subsidiary, Adcock Ingram Healthcare Private
Limited, of certain assets of Cosme Farma Laboratories Limited (“Cosme”) (“the Transaction”) and are advised
that the regulatory approvals in India are still in process. The previously anticipated closing date for the
Transaction, being 31 October 2012, has not been achieved. In terms of an extension agreement entered into
between Adcock Ingram and Cosme the closing date for the Transaction has been extended to 31 January
2013.
Midrand
01 November 2012
Sponsor
Deutsche Securities (SA) Proprietary Limited
Date: 01/11/2012 10:16:00 Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE').
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct,
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
information disseminated through SENS.
Profile Group (Pty) Ltd. has taken care in preparing all information on this website, but does not accept any liability for errors or out-of-date information.
